Extended-interval dosing of natalizumab in NOVA Reply

被引：0
|
作者：
Foley, John F. [1 ]
Campbell, Nolan [2 ]
Kong, George [2 ]
机构：
[1] Rocky Mt Multiple Sclerosis Clin, Salt Lake City, UT 84103 USA
[2] Biogen, Cambridge, MA USA
来源：
LANCET NEUROLOGY | 2023年 / 22卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：200 / 201
页数：2
相关论文
共 50 条
  • [21] Natalizumab Extended Interval Dosing: Real Life Experience
    Jacques, Francois
    Lebel, Marie-Christine
    Timite, Halilou
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 1016 - 1017
  • [22] Safety of extended interval dosing of Natalizumab in clinical practice
    Pastor, S.
    Fernandez-Fournier, M.
    Sastre Real, M.
    Perez Lucas, J.
    Puertas Munoz, I.
    Tallon, A.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2017, 24 : 335 - 336
  • [23] Pharmacodynamics and pharmacokinetics of natalizumab administered at extended interval dosing
    Ryerson, L. Zhovtis
    Zuniga-Estrada, G.
    Jacob, A.
    Bacon, T.
    Pandey, K.
    Mohn, J.
    Kister, I.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 917 - 918
  • [24] Extended Interval Dosing of Natalizumab: A Single Center Experience
    Alderazi, Yazan J.
    Campagnolo, Denise
    Bomprezzi, Roberto
    [J]. NEUROLOGY, 2011, 76 (09) : A614 - A614
  • [25] Lymphocyte response in standard and extended interval dosing of natalizumab
    Rafee, S.
    Kennelly, L.
    Mcguigan, C.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 170 - 170
  • [26] A meta-analysis of extended-interval dosing versus multiple daily dosing of aminoglycosides
    Bailey, TC
    Little, JR
    Littenberg, B
    Reichley, RM
    Dunagan, WC
    [J]. CLINICAL INFECTIOUS DISEASES, 1997, 24 (05) : 786 - 795
  • [27] Eight years' experience of an extended-interval dosing protocol for gentamicin in neonates
    Begg, Evan J.
    Vella-Brincat, Jane W. A.
    Robertshawe, Barbara
    McMurtrie, Mark J.
    Kirkpatrick, Carl M. J.
    Darlow, Brian
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2009, 63 (05) : 1043 - 1049
  • [28] Determination of extended-interval gentamicin dosing for neonatal patients in developing countries
    Darmstadt, Gary L.
    Hossain, M. Monir
    Jana, Atanu Kumar
    Saha, Samir K.
    Choi, Yoonjoung
    Sridhar, S.
    Thomas, Niranjan
    Miller-Bell, Mary
    Edwards, David
    Aranda, Jacob
    Willis, Jefftey
    Coffey, Patricia
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2007, 26 (06) : 501 - 507
  • [29] Extended-interval dosing of tobramycin in neonates: Implications for therapeutic drug monitoring
    de Hoog, M
    Mouton, JW
    Schoemaker, RC
    Verduin, CM
    van den Anker, JN
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 71 (05) : 349 - 358
  • [30] Natalizumab: extended versus standard interval dosing in the real world
    Wagner, B.
    Richter, S.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 880 - 881
12345